Current Report Filing (8-k)
August 13 2018 - 8:07AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported):
August 13, 2018
MEDICAL
TRANSCRIPTION BILLING, CORP.
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-36529
|
|
22-3832302
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
7
Clyde Road, Somerset, New Jersey, 08873
(Address of principal executive offices, zip code)
(732)
873-5133
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [X]
Item
7.01 Regulation FD Disclosure.
The
Registrant is hereby furnishing the following information under Regulation FD:
On
August 13, 2018, the Registrant issued a press release announcing that its Board of Directors has declared monthly cash dividends
for its 11% Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”) for September 2018
through November 2018.
A
copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
Safe
Harbor Statement
Statements
contained in the exhibit to report that state the Company’s or its management’s expectations or predictions of the
future are forward-looking statements intended to be covered by the safe harbor provisions of the Securities Act of 1933, as amended,
and the Securities Exchange Act of 1934, as amended. It is important to note that the Company’s actual results could differ
materially from those projected in such forward-looking statements. The Company does not assume any obligations to update the
forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were
made.
Item
9.01 Financial Statements and Exhibits
SIGNATURE(S)
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
Medical
Transcription Billing, Corp.
|
|
|
|
Date:
August 13, 2018
|
By:
|
/s/
Stephen Snyder
|
|
|
Stephen
Snyder
Chief
Executive Officer
|
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Sep 2024 to Oct 2024
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about CareCloud Inc (NASDAQ): 0 recent articles
More Medical Transcription Billing, Corp News Articles